Clinical trial
A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical…
NCT00369018 · Photocure, Industry · Completed
Key facts
| NCT number | NCT00369018 |
|---|---|
| Title | A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions. |
| Official title | Methyl Aminolevulinate (MAL) and Hexaminolevulinate (HAL) Photodynamic Therapy (PDT)of Cervical Intraepithelial Lesions (SIL) - a Double-blind Dose-finding Study |
| Lead sponsor | Photocure, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Dysplasia |
| Intervention type | Drug |
| Interventions | methyl aminolevulinate (MAL) and hexaminolevulinate (HAL) |
| Enrollment | 96 |
| Start date | Aug 1, 2006 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Aug 29, 2006 |
| Last update posted | Nov 30, 2010 |
| Countries | Germany, Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: